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Introduction {#sec001}
============

The high diversity of HIV-1 has led to its classification into four groups named M, N, O and P. Group M which is the most prevalent worldwide has been further subdivided into at least nine genetically distinct subtypes or clades (A-D, F-H, J, and K), several circulating recombinant forms (CRFs) and unique recombinant forms (URFs) \[[@pone.0195661.ref001]\]. Several studies have reported the impact of HIV-1 strains on transmission, replication, pathogenesis, diagnosis and response to therapy \[[@pone.0195661.ref002], [@pone.0195661.ref003]\]. Thus, subtype A was shown to be less pathogenic than non-A subtypes and to have a lower replication rate than subtype C \[[@pone.0195661.ref004], [@pone.0195661.ref005]\]. The heterosexual transmission rate of HIV-1 appeared to be higher in subtype A compared with D, and in CRF01_AE compared with subtype B \[[@pone.0195661.ref006], [@pone.0195661.ref007]\]. Subtype D has been associated with faster disease progression compared with subtype A, C and CRFs \[[@pone.0195661.ref008]--[@pone.0195661.ref010]\]. The overall influence of inter- and intra-clade genetic variability on the biological properties of HIV-1 is not fully understood. However, there is increasing evidence that the genetic diversity of the LTR has the potential to affect the replication rate and expression of HIV-1 \[[@pone.0195661.ref011]--[@pone.0195661.ref014]\]. For example, it was shown that a single mutation changing one of the two canonical targets for NF-κB into a binding site for GABP transcription factor, results in higher replication rate and transmission efficiency of CRF01_AE compared with subtype B \[[@pone.0195661.ref015]\]. Also, mutations in the sequence motifs targeted by the `CCAAT`/enhancer-binding proteins (C/EBP) and specificity proteins 1 (Sp1) were correlated with disease severity and neurologic impairment \[[@pone.0195661.ref016], [@pone.0195661.ref017]\].

During the life cycle of HIV-1, transcriptional regulation of the integrated provirus is a key step ahead of viral replication and expression. This early step is regulated by a synergistic interaction of host transcription factors and viral proteins that bind to specific targets in the 5'LTR of the HIV-1 genome. The HIV-1 5'LTR is a complex structure of approximately 640 bp in length with a high concentration of transcription factor binding sites (TFBS). It has been divided into the U3, R and U5 functional regions. The U3 region located upstream of the transcription start site was subdivided into the modulatory (nt -454 to -104), the enhancer (nt -105 to -79) and the promoter (nt -78 to -1) segments \[[@pone.0195661.ref013], [@pone.0195661.ref018]\]. The modulatory segment contains numerous TFBS \[[@pone.0195661.ref019]\], and in certain HIV-1 variants, this segment is extended with an insert of 15 to 34 nucleotides known as the Most Frequent Naturally occurring Length Polymorphism (MFNLP) \[[@pone.0195661.ref020]--[@pone.0195661.ref022]\]. The enhancer region contains binding sites for the NF-kB family of transcription factors, and the promoter region carries the TATA box and three binding sites for Sp1 \[[@pone.0195661.ref018]\]. Following the promoter, the R region which is, by definition, the transcription initiation site comprises the trans-activating responsive (TAR) element that mediates activation of transcription through its binding to the viral Tat protein \[[@pone.0195661.ref023], [@pone.0195661.ref024]\], and the polyadenylation signal (poly A) involved in the addition of the 3\'-poly (A) tail \[[@pone.0195661.ref025]\]. Along with these elements, various binding sites for different families of transcription factors have also been described in the R region \[[@pone.0195661.ref026]--[@pone.0195661.ref029]\]. Interaction between the TAR element and the viral protein Tat is required to enhance transcriptional elongation and gene expression of HIV-1 \[[@pone.0195661.ref030], [@pone.0195661.ref031]\]. However, prior to the presence of Tat, the 5'LTR is able to support basal transcription that results in the production of short transcripts allowing viral proteins such as Tat to be made \[[@pone.0195661.ref031]\]. This capacity of the 5'LTR to control HIV-1 basal transcription is driven by TFBS in the U3 promoter and enhancer segments primarily \[[@pone.0195661.ref031]\], but also involves cooperative action of regulatory elements in the U3 modulatory segment \[[@pone.0195661.ref032]\]. Besides its role in transcription, the U3 and the R region of the 5'LTR (U3R) have also been involved in HIV-1 replication, expression and silencing \[[@pone.0195661.ref033]--[@pone.0195661.ref038]\]. Therefore, characterization of the U3R from different HIV-1 strains is of great importance as it might contribute to a better understanding of the influence of HIV-1 variants on the fitness, pathogenicity and disease progression. To date, only few studies have investigated the genetic diversity the HIV-1 5'LTR in non-B and non-C strains and in most of them the common approach was the clone-based Sanger sequencing methodology \[[@pone.0195661.ref039]--[@pone.0195661.ref041]\]. This method is costly, time-consuming and labor intensive. Also, it may be limited by preferential selection that can occur during molecular cloning and only a few hundred clones can be generated and sequenced \[[@pone.0195661.ref042], [@pone.0195661.ref043]\]. Next-generation sequencing (NGS) technology is a relevant alternative to overcome these limitations by allowing massively parallel amplification at high coverage of thousands of reads per base pair. Thus, NGS provides the potential to reduce the time and facilitate the detection of intra-specimen variability without the need for cloning PCR amplicons before sequencing. The main objective of this study is to describe the genetic variability of the U3R from viruses representing various clades and diverse CRFs isolated from plasmas samples, by using NGS Illumina sequencing technology.

Materials and methods {#sec002}
=====================

Specimens and RNA isolation {#sec003}
---------------------------

Sixty five high titer virus derived from de-identified plasma specimens obtained from DUKE EQAPOL viral diversity program \[[@pone.0195661.ref044]\], and five CRF02_AG virus isolated from stored and de-identified plasma specimens \[[@pone.0195661.ref045]--[@pone.0195661.ref047]\] as previously described \[[@pone.0195661.ref048]\] were selected for this study. The study was approved by the Duke University Institutional Review Board for clinical investigation (Pro0029507) and the Review Board of the US HHS/Food and Drug Administration Research in Human Subjects Committee (exempt reference number 01-044B). The selected seventy virus stocks included clade B (n = 18), clade A1 (n = 10), clade C (n = 9), clade D (n = 8), clade F2 (n = 3), clade G (n = 4), CRF02_AG (n = 9), CRF01_AE (n = 5), CRF22_01A1 (n = 4). Viral RNA was extracted using Virus QIAamp Viral RNA Mini Kit (QIAGEN) according to the manufacturers' instructions.

Primer design {#sec004}
-------------

References and consensus sequences representing the first 1000 nucleotides of the HIV-1 genome from multiple subtypes and CRFs were downloaded from Los Alamos National Laboratory HIV database and aligned in MEGA version 7 software \[[@pone.0195661.ref049]\]. Regions with the highest degree of conservation were screened and used to design PCR primers that were optimized for melting temperatures, GC content and reduced hairpin and/or primer dimer formation (NCBI/primer3-BLAST; SMS). Due to mismatches in some strains, selected primers were designed with degenerate nucleotides to match all group M isolates.

cDNA synthesis, PCR amplification and purification {#sec005}
--------------------------------------------------

Reverse transcription was performed by using Superscript III First-strand synthesis System for RT-PCR (Invitrogen 18080--051). The cDNA was amplified by touchdown (TD) polymerase chain reaction (PCR) procedure with 2 rounds of amplification. Each amplification run was performed in a 50μl reaction volume using Promega PCR master mix (Promega, Madison, WI, USA cat M7505) supplemented with 0.4μM of primer [Table 1](#pone.0195661.t001){ref-type="table"}. Cycling conditions for both outer and nested TD-PCR was as follows: initial incubation at 95°C for 3 min followed by 10 cycles at 95°C for 30 s, 64°C for 30 s with a 1°C decrement per cycle, and 72°C for 50 s. Subsequently, 25 cycles were performed at 95°C for 30 s, 55°C for 30 s, and 72°C for 50 s followed by a final extension of 5 min at 72°C. The second round PCR amplicons were separated by gel electrophoresis. The expected PCR product size of about 850 pb were excised from the gel and purified using QIAquick Gel Extraction Kit (Qiagen).

10.1371/journal.pone.0195661.t001

###### Primers used for amplification of the 5'end of the HIV-1 genome.

![](pone.0195661.t001){#pone.0195661.t001g}

  Primers         Reaction                         Sequence (5'to 3')         Position [^a^](#t001fn002){ref-type="table-fn"}
  --------------- -------------------------------- -------------------------- -------------------------------------------------
  HF01F (+)       cDNA                             `TGGAAGGGCTAATTTGGTCCCA`   1--22
  UNINEF 7' (-)   `GCACTCAAGGCAAGCTTTATTGAGGCTT`   9605--9632                 
  HF01Fd (+)      1^st^ PCR                        `TGGAWGGGYTAATTTGGTCCCA`   1--22
  RVN910_M (-)    `GCTCCCTGCTTGCCCATACT`           891--910                   
  5\'NCF1_M (+)   2^nd^ PCR                        `GGMTWCTTCCCTGATTGGCA`     66--85
  PBSBR (-)       `CTTAATACCGACGCTCTCGCACCCAT`     790--815                   

(+), forward primer; (-) Reverse primer;

^a^ Position according to the HXB2 coordinates

Ultra-deep sequencing {#sec006}
---------------------

Miseq (Illumina, San Diego, CA) sequencing of the gel purified PCR product was carried out at the core facility of the Food and Drug Administration (FDA, White oak, MD, USA). Briefly, concentration of purified amplicons was measured by using Qubit dsDNA BR Assay System (Covaris, Woburn, MA, USA) and (2 ng of DNA purified product was processed for NGS library preparation using the Nextera XT DNA Sample Preparation Kit. Specimens were run in the Miseq instrument using a MiSeq v2 kit (500 cycles) to produce paired-end reads of approximately 250pb. After automated cluster generation in MiSeq, the sequencing was processed and fastq files were generated.

Sequence analysis {#sec007}
-----------------

All fastq files were imported into CLC Genomics Workbench version 9.0 (CLC bio/Qiagen, Aarhus, Denmark) using default option. Reads were paired and trimmed to obtain reads with an average Phred score ≥ 20. Contigs were generated using de novo assembly tools with the default options. The reads were mapped back to contigs using previous published parameters \[[@pone.0195661.ref050]\]. For characterization of the 5'LTR region, the minimum contig length was set at 400bp. For each specimen, contigs with a minimum coverage of 1000 reads were exported from the assembly and used for further analysis. The subtype of each full length LTR contig was assigned using COMET HIV-1 subtype tool \[[@pone.0195661.ref051]\]. Sequences from the same subtypes were aligned in MEGA 7 using the 5'end of HXB2 sequence (from nucleotide 76 to 850, K03455) as a reference to position the U3R sequence and to locate regulatory motifs. Mutations were identified by comparing sequences from each HIV-1 studied strain to the reference HXB2 and within matched subtype. Identification of potential TFBS was based on similarity with a reported binding site pattern and prediction with the Match 1.0 Public program available online (<http://gene-regulation.com/pub/programs.html>). A pairwise comparison in CLC Genomics Workbench was used to calculate the percentage of identity.

Results {#sec008}
=======

Subtype assignment {#sec009}
------------------

Near full length LTR sequences were not obtained for 11% (8/70) of selected specimens due to failure in amplification and /or sequencing. From the 62 specimens successfully sequenced, more than one contig was obtained for several specimens. Thus, we retrieved a total of 80 contigs that were subtyped as follows: clade B (n = 20), CRF12_BF (n = 5), clade C (n = 8), clade D (n = 10), clade F2 (n = 5), clade G (n = 3), clade A1 (n = 10), CRF02_AG (n = 9) and CRF01_AE (n = 10). For majority of the sequences analyzed, the subtype assigned to the 5'LTR of the HIV-1 isolate was concordant with its previously reported primary genotype \[[@pone.0195661.ref044]--[@pone.0195661.ref046], [@pone.0195661.ref052]\]. However, we found that additional contigs from 5 clade B specimens were subtyped as CRF12_BF (BF), one of the two contigs from a CRF02_AG (AG) specimen was assigned to be F2, and all the LTR sequences retrieved from the CRF22_01A1 (01A1) specimens were subtyped as CRF01_AE (AE) [Table 2](#pone.0195661.t002){ref-type="table"}.

10.1371/journal.pone.0195661.t002

###### Specimens description and LTR subtype assignment.

![](pone.0195661.t002){#pone.0195661.t002g}

  Original ID                                         Country of origin   Primary genotype   Source Genbank   LTR ID           LTR subtype   Genbank
  --------------------------------------------------- ------------------- ------------------ ---------------- ---------------- ------------- ----------
  DEMB10US007                                         USA                 B                  KC473828         DEMB10US007      B             MH045863
  DEMB10US011                                         USA                 B                  KC473830         DEMB10US011      B             MH045864
  DEMB10US003                                         USA                 B                  KC473826         DEMB10US003      B             MH045865
  DEMB10US004                                         USA                 B                  KC473827         DEMB10US004      B             MH045866
  DEMB11US004                                         USA                 B                  KC473832         DEMB11US004      B             MH045867
  DEMB10US009[\*](#t002fn002){ref-type="table-fn"}    USA                 B                  KC473829         DEMB10US009_1    B             MH045868
  DEMB10US009_2                                       CRF12_BF            MH045869                                                           
  DEMB05FR001                                         France              B                  JX140652         DEMB05FR001      B             MH045870
  DEMB08FR002[\*](#t002fn002){ref-type="table-fn"}    France              B                  JX140654         DEMB08FR002_1    B             MH045871
  DEMB08FR002_2                                       B                   MH045872                                                           
  DEMB10CN002[\*](#t002fn002){ref-type="table-fn"}    China               B                  JX140658         DEMB10CN002_1    B             MH045873
  DEMB10CN002_2                                       B                   MH045874                                                           
  DEMB10VE001                                         Venezuela           B                  JX140659         DEMB10VE001      B             MH045875
  DEMB03JP004[\*](#t002fn002){ref-type="table-fn"}    Japan               B                  KC473846         DEMB03JP004_1    B             MH045876
  DEMB03JP004_2                                       B                   MH045877                                                           
  DEMB03JP004_3                                       CRF12_BF            MH045878                                                           
  DEMB10ES003[\*](#t002fn002){ref-type="table-fn"}    Spain               B                  KC473843         DEMB10ES003_1    B             MH045879
  DEMB10ES003_2                                       CRF12_BF            MH045880                                                           
  DEMB10ES002                                         Spain               B                  KC473842         DEMB10ES002      B             MH045881
  DEMB09ES007                                         Spain               B                  KC473841         DEMB09ES007      B             MH045882
  DEMB12JP001                                         Japan               B                  KF716498         DEMB12JP001      B             MH045883
  DEMB09FR001[\*](#t002fn002){ref-type="table-fn"}    France              B                  KF716494         DEMB09FR001_1    B             MH045884
  DEMB09FR001_2                                       CRF12_BF            MH045885                                                           
  DEMB09BO001[\*](#t002fn002){ref-type="table-fn"}    Bolivia             B                  JX140656         DEMB09BO001_1    B             MH045886
  DEMB09BO001_2                                       CRF12_BF            MH045887                                                           
  DEMC08ZA011                                         South Africa        C                  JX140666         DEMC08ZA011      C             MH045888
  DEMC09MW007                                         Malawi              C                  KP109524         DEMC09MW007      C             MH045889
  DEMC09MW009                                         Malawi              C                  KP109526         DEMC09MW009      C             MH045890
  DEMC00IN009                                         India               C                  KP109484         DEMC00IN009      C             MH045891
  DEMC12ZA087                                         South Africa        C                  KP109516         DEMC12ZA087      C             MH045892
  DEMC00IN006[\*](#t002fn002){ref-type="table-fn"}    India               C                  KP109481         DEMC00IN006_1    C             MH045893
  DEMC00IN006_2                                       C                   MH045894                                                           
  DEMC00IN007                                         India               C                  KP109482         DEMC00IN007      C             MH045895
  DEMD07UG007                                         Uganda              D                  KF716503         DEMD07UG007      D             MH045896
  DEMD07UG002[\*](#t002fn002){ref-type="table-fn"}    Uganda              D                  KC596071         DEMD07UG002_1    D             MH045897
  DEMD07UG002_2                                       D                   MH045898                                                           
  DEMD08UG001                                         Uganda              D                  KC596072         DEMD08UG001      D             MH045899
  DEMD10UG004[\*](#t002fn002){ref-type="table-fn"}    Uganda              D                  KF716479         DEMD10UG004_1    D             MH045900
  DEMD10UG004_2                                       D                   MH045901                                                           
  DEMD11UG003[\*](#t002fn002){ref-type="table-fn"}    Uganda              D                  KF716480         DEMD11UG003_1    D             MH045902
  DEMD11UG003_2                                       D                   MH045903                                                           
  DEMD11UG003_3                                       D                   MH045904                                                           
  DEMD10CM009                                         Cameroon            D                  JX140670         DEMD10CM009      D             MH045905
  DEMF110ES001                                        Spain               F1                 JX140671         DEMF110ES001     F2            MH045906
  DEMF210CM001[\*](#t002fn002){ref-type="table-fn"}   Cameroon            F2                 JX140672         DEMF210CM001_1   F2            MH045907
  DEMF210CM001_2                                      F2                  MH045908                                                           
  DEMF210CM007                                        Cameroon            F2                 JX140673         DEMF210CM007     F2            MH045909
  NYU6542[\*](#t002fn002){ref-type="table-fn"}        Cameroon            CRF02_AG           NA               NYU6542_1        F2            MH045910
  NYU6542_2                                           CRF02_AG            MH045911                                                           
  DE00208CM004                                        Cameroon            CRF02_AG           JX140647         DE00208CM004     CRF02_AG      MH045912
  DE00208CM001                                        Cameroon            CRF02_AG           JX140646         DE00208CM001     CRF02_AG      MH045913
  MDC-021                                             Cameroon            CRF02_AG           NA               MDC-021          CRF02_AG      MH045914
  MDC-024                                             Cameroon            CRF02_AG           NA               MDC-024          CRF02_AG      MH045915
  MDC-046                                             Cameroon            CRF02_AG           NA               MDC-046          CRF02_AG      MH045916
  MDC-055[\*](#t002fn002){ref-type="table-fn"}        Cameroon            CRF02_AG           NA               MDC-055_1        CRF02_AG      MH045917
  MDC-055_2                                           MH045918                                                                               
  MDC-067                                             Cameroon            CRF02_AG           NA               MDC-067          CRF02_AG      MH045919
  DEMG09KE001                                         Kenya               G                  KF716477         DEMG09KE001      G             MH045920
  DEMG09ES002                                         Spain               G                  JX140675         DEMG09ES002      G             MH045921
  DEMG10CM008                                         Cameroon            G                  JX140676         DEMG10CM008      G             MH045922
  DE00109CN003                                        China               CRF01_AE           KC596061         DE00109CN003     CRF01_AE      MH045923
  DE00109CN004                                        China               CRF01_AE           KC596062         DE00109CN004     CRF01_AE      MH045924
  DE00110CN001                                        China               CRF01_AE           KC596063         DE00110CN001     CRF01_AE      MH045925
  DE00111CN003                                        China               CRF01_AE           KC596065         DE00111CN003     CRF01_AE      MH045926
  DE00111CN002                                        China               CRF01_AE           KC596064         DE00111CN002     CRF01_AE      MH045927
  DE02210CM010                                        Cameroon            CRF22_01A1         KF716460         DE02210CM010     CRF01_AE      MH045928
  DE02210CM011                                        Cameroon            CRF22_01A1         KF716461         DE02210CM011     CRF01_AE      MH045929
  DE02210CM014                                        Cameroon            CRF22_01A1         KF716463         DE02210CM014     CRF01_AE      MH045930
  DE02210CM012[\*](#t002fn002){ref-type="table-fn"}   Cameroon            CRF22_01A1         KF716462         DE02210CM012_1   CRF01_AE      MH045931
  DE02210CM012_2                                      MH045932                                                                               
  DEMA03RW001                                         Rwanda              A1                 KF716499         DEMA03RW001      A1            MH045933
  DEMA11KE001                                         Kenya               A1                 KF716475         DEMA11KE001      A1            MH045934
  DEMA110UG001                                        Uganda              A1                 KF859745         DEMA110UG001     A1            MH045935
  DEMA108RU003                                        Russia              A1                 KF716491         DEMA108RU003     A1            MH045936
  DEMA108RU004                                        Russia              A1                 KF716492         DEMA108RU004     A1            MH045937
  DEMA106ES002                                        Spain               A1                 JX140651         DEMA106ES002     A1            MH045938
  DEMA110UG009                                        Uganda              A1                 KF716486         DEMA110UG009     A1            MH045939
  DEMA105TZ001                                        Tanzania            A1                 JX140650         DEMA105TZ001     A1            MH045940
  DEMA07RW002[\*](#t002fn002){ref-type="table-fn"}    Rwanda              A1                 KP109528         DEMA07RW002_1    A1            MH045941
  DEMA07RW002_2                                       MH045942                                                                               

NA, not available;

\*highlighted in gray are specimens in which more than one contig was retrieved

Variability of the U3R region of the 5'LTR {#sec010}
------------------------------------------

Compared to HXB2, the U3 region was the most conserved in clade B with about 88% nucleotide identity versus less than 80% in average for all the other strains. The variability of the U3 region was less than 12% between sequences from the same strains and increased to an average of 23% between sequences from different strains. For most of our studied strains, the highest variability was found in the U3 modulatory segment with less than 75% of nucleotide identity. Nevertheless, the enhancer segment of clade C 5'LTRs share less than 65% of identity with the other strains. Although the number of mutations were higher in the modulatory segment than in the other segments of the U3 region, it also appears to be well conserved within sequences from the same HIV-1 strain (\>85% of nucleotides identity). In the enhancer segment the intra-strain diversity varied from 2% (CRF01_AE) to 26% (CRF02_AG), while it was about 6% in the promoter segment. With an average nucleotide identity of 85%, this latter segment of the U3 region displayed few changes when sequences from different strains were compared.

Variability of the U3 region {#sec011}
----------------------------

### U3 modulatory spanning nucleotides -378 to -176 {#sec012}

Numerous transcription factors have been described in this portion of the U3 modulatory segment \[[@pone.0195661.ref013]\]. Nucleotide sequence from -378 to -364 which encompasses targets for proteins related to the NF-1 and CREB/ATF family of transcription factors \[[@pone.0195661.ref053], [@pone.0195661.ref054]\], include the `CTGATTGGC` motif (nt -378 to -370) that was conserved in 56% of the sequences analyzed. Its variant `CAGATTGGC` was mainly observed in the CRFs as well as in clades G and D specimens, while `CAGACTGGC` was shown in 1/3 of the CRF02_AG specimens ([Fig 1A](#pone.0195661.g001){ref-type="fig"}). The adjacent sequence (nt -369 to -364) with the consensus motif `AGAA(C/T)T` was conserved in 55% of the sequences analyzed, while other variants such as `ACAACT` were mainly found in CRF01_AE and CRF22_01A1 viruses ([Fig 1A](#pone.0195661.g001){ref-type="fig"}). TFBS such as COUP-TF, AP-1, ETS-1 and GATA have been reported within the sequence spanning nt -356 to -325 \[[@pone.0195661.ref055]--[@pone.0195661.ref057]\]. In our dataset, the first half of the binding site for COUP/AP-1 (`AGGGCCA`; nt -356 to -350) was highly conserved (80%) with few variants such as the consensus `G(G/C)GACCA` found in clade C LTRs ([Fig 1A](#pone.0195661.g001){ref-type="fig"}). On the contrary, the second half of this TFBS (nt -349 to -343) which includes a functional target for AP-1 family of proteins (AP-1 (II)), was more variable ([Fig 1A](#pone.0195661.g001){ref-type="fig"}). AP1 (II) overlaps a GATA binding site (nt -343 to -338) with the motifs `AGATT(T/C)` mostly found in F2, CRF12_BF, G and CRF02_AG LTRs, and `AGATA(T/C)` predominant in all the other studied strains. Further downstream (nt -333 to -327), the `TGACCTT` consensus for the reported AP-1(I), was found in all the strains studied except in CRF01_AE, CRF22_01A 1 and in clade A1 viruses. Indeed, the AP-1 (I) variant `TATGTTT` was shared by 80% of CRF01_AE and 40% of CRF22_01A1 specimens. In the remaining sequence from CRF22_01A1 viruses, the consensus sequence `TGTG(T/C)TT` was found. In clade A1 LTRs, the variant `TAACATT` generates with its 3'end overlapping nucleotides a `CATTTG` motif (nt -330 to -325), that matches the E-box consensus `CANNTG` ([Fig 1A](#pone.0195661.g001){ref-type="fig"}).

![Variability in the U3 modulatory region of diverse HIV-1 subtypes and CRFs.\
N = any base; W = A or T; R = A or G; Y = C or T; K = G or T; M = A or C; S = G or C; D = A, G or T; H = A, C or T; B = C, G or T.](pone.0195661.g001){#pone.0195661.g001}

Contiguously, the GATA-like binding site `GGATGG` (nt -326 to -319) \[[@pone.0195661.ref058]\], was mutated to `GGGTGG` in CRF02_AG LTRs and in some sequences from various other strains ([Fig 1A](#pone.0195661.g001){ref-type="fig"}). The consensus `TGCTACAAG(C/T)` (nt -320 to -310) of the first half of the binding site for the negative regulator of transcription (NRT-1)\[[@pone.0195661.ref059]\], was mainly conserved in CRF22_01A1 (80%) isolates. It was changed to a TGCTTCAAG(C/T) consensus in a majority of non -CRF02_AG, non- clade G and D specimens, and to TG(C/T)TTCAAAC variant in clade G and CRF02_AG LTRs. The second half of the NRT-1 was reported to include an E-box/c-Myb and AP-1 sites \[[@pone.0195661.ref060]\]. In our study, the E-box consensus (CANNTG, nt -303 to -298) was not found in clade G and CRF02_AG LTRs. It was replaced by the non-specific variant CA(A/G)TGG also shared with others strains such as CRF22_01A1 isolates ([Fig 1A](#pone.0195661.g001){ref-type="fig"}). This latter variant also modified the overlapping AP-1 motif (nt -299 to -293). The contiguous GATA target \[[@pone.0195661.ref060], [@pone.0195661.ref061]\], displayed two major variants in our study ([Fig 1A](#pone.0195661.g001){ref-type="fig"}), GGTAGA (45%) and AGTAGA (26%) that were closely related but not identical to the canonical (A/T)GATA(A/G) binding site for GATA factors. Nucleotides spanning the AP1-1 and GATA binding sites (nt -296 to -283) lead to a consensus with a fairly high variability in LTRs from clades B and A as well as CRF02_AG specimens, but with some specific patterns in the other strains analyzed. The HXB2 sequence GCCAGAGAAGTTAG was mutated to [C]{.ul}CCA[AG]{.ul}G[G]{.ul}A[AG]{.ul}TAG in clade C, to [T(G]{.ul}/C)CA[A]{.ul}AG[G]{.ul}A[GG]{.ul}([C]{.ul}/T)AG in clade D, and to [T]{.ul}CCA[AGAG]{.ul}A[AG]{.ul}TAG in CRF22_01A1 isolates. These variants probably contain specific TFBS, as observed with the clade D included motif [A]{.ul}AG[G]{.ul}A[G]{.ul} that matches a recognition site for Ets-2 \[[@pone.0195661.ref062]\].

In the subsequent sequence, motifs such as `(G/A)AAGGC` (nt -283 to -277), fitting the canonical motif for GABP factors \[[@pone.0195661.ref063]\], was observed in all F2 and CRF12_BF as well as in A1 (70%) and B (25%). The `AACAAAG` motif (nt -274 to -268) conformed to the LEF-1/TCF consensus \[[@pone.0195661.ref064]\], was conserved only in LTRs from CRF01_AE (100%) and CRF22_01A1 (40%). In 60% of CRF22_01A1 and in 33% of CRF02_AG isolates, the LEF-1/TCF motif was changed to a homologue of the polyadenylation signal motif `AATAAA` ([Fig 1B](#pone.0195661.g001){ref-type="fig"}). The overlapping consensus `(A/C)AGGAG` (nt -270 to -265) which resembles a binding site for NFAT and Ets-2 factors \[[@pone.0195661.ref062], [@pone.0195661.ref065]--[@pone.0195661.ref067]\], was fairly well conserved across almost all our analyzed sequences except for majority of sequences from clades A1 and G isolates ([Fig 1B](#pone.0195661.g001){ref-type="fig"}). Overlapping the NFAT footprint \[[@pone.0195661.ref068]\], the consensus motif `CAACTG` (nt -260 to -255) perfect fit to the E-box /c-Myb consensus \[[@pone.0195661.ref069], [@pone.0195661.ref070]\], was mainly found in non-A1, non-G and non-CRFs specimens. In 60% of the sequence assigned to be CRF01_AE, we found the variant `CAGCTG` similar to the recognition site for the AP4 factor \[[@pone.0195661.ref071]\]. On the other hand, the c-Myb variant (`C/T)AACAG`, predominant in sequences from CRF02_AG (100%), G (67%) and A1 (60%) specimens, was also found in clades C (38%) and B (20%).

Although it displayed one nucleotide mismatch with the `(C/A)TTNCNN(C/A)A` consensus described as the best fit for the binding of the C/EBP family of transcription factors \[[@pone.0195661.ref072]--[@pone.0195661.ref074]\], the sequence `CTTGTTACA` in HXB2 (nt -254 to -246) was reported as a C/EBPβ target (US3). In our study, the US3 consensus (`CTTNTNNCA`) was found in at least 60% of clades B, D and G assigned LTRs, and the variant `TTTNCNNCA` mainly found in clade C LTR was also shown to be able to bind C/EBP proteins \[[@pone.0195661.ref074]--[@pone.0195661.ref076]\]. In most of the other studied strains, variants of the US3 generally included more than one nucleotide mismatches with the C/EBP consensus motif ([Fig 1C](#pone.0195661.g001){ref-type="fig"}). The adjoining sequence (nt -244 to -234) seemed to include various overlapping TFBS with some strain specific motifs ([Fig 1C](#pone.0195661.g001){ref-type="fig"}). Thus, at the relative location of the GATA-like motif `CCTAT(G/A)` (nt -244 to -239) that was found in non-clade G and non--CRFs isolates, the `CCCATG` variant was shown in LTRs subtyped as CRF01_AE only, while `CCCATC` was found in clade G and CRF02_AG only. Subsequently, we observed a CREB/ATF/AP-1-like binding site in several studied isolates, except for clade G and CRF02_AG. In these latter specimens, we found an E-box with the sequence motif `CATCTG`. Majority of sequences subtyped as F2 (60%), CRF12_BF (80%) as well as some clade B (25%) displayed a `TATAA` motif within nucleotides spanning this location ([Fig 1C](#pone.0195661.g001){ref-type="fig"}). Further downstream, the nucleotide sequence includes a potential Ets/GATA- like element (nt- 232 to -222) and other various potential TFBS such as `TGACCC(A/G)` in clade B or `TGA(G/T)GA(A/G)` in clade A1 which resemble were a CREB/ATF/AP-1 target (nt -221 to -212).

The sequence `GAGAGAGAAGTG` in HXB2 (nt -216 to -203), reported to encompass a second NFAT footprint in this segment of the U3 region \[[@pone.0195661.ref065], [@pone.0195661.ref068]\], was mainly conserved in clade D isolates. In our dataset, this NFAT footprint displayed strain specific mutations generating motif that might potentially be recognized by other transcription factor ([Fig 1C](#pone.0195661.g001){ref-type="fig"}). For example, the `GAGAAAGAAGT(G/A)` consensus was mainly found in clade B LTRs (45%) include C/EBP-like motif, while the `GA(C/T)A(G/A)A(G/A)ARGTG` variant predominant in CRF02_AG isolates includes a GATA-like motif. The highest variability of this NFAT footprint was found in clade A1 isolates in which we noticed that 50% of the variants contain a `GAAACAT` motif (nt -208 to -202) closely related to the LEF-1/TCF recognition site \[[@pone.0195661.ref064]\]. The adjacent motif `TAGAGTGGA` (nt -201 to -193) displayed some specific motifs in most of the HIV-1 non-B strains with some the variant containing an AP-1/ATF/CREB-like motif ([Fig 1C](#pone.0195661.g001){ref-type="fig"}). The following nucleotide sequence (nt -188 to -182) was characterized by low intra-clade variability and majority of the variants found contain a motif homologous to the AP-1/ATF/CREB family of proteins target ([Fig 1C](#pone.0195661.g001){ref-type="fig"}).

### U3 modulatory spanning nucleotides -176 to -106 {#sec013}

Several consensus binding sites for transcription factors such as C /EBP, USF-1, Ets, LEF-1 and RBF-2 have been described within the nucleotide sequence from position -176 to the end of the modulatory segment \[[@pone.0195661.ref041], [@pone.0195661.ref073], [@pone.0195661.ref077]--[@pone.0195661.ref079]\]. In this part of the U3 region, the US2 and US1 targets for C/EBP proteins were reported within the HXB2 sequence `AGCATTTCATCA` (nt -176 to -165) and `AGCTTGCTACA` (nt -116 to -106) respectively \[[@pone.0195661.ref080]\]. In our study, the consensus motif `(A/G)GC(A/C)TTNC(A/G)NCA` found in clades B (95%) and A1 (20%) was the only US2 variant conformed to the canonical binding site for C/EBP proteins. Non-canonical distinct variants were observed among non-B strains and some of them displayed up to three nucleotides mismatches with the consensus ([Fig 1D](#pone.0195661.g001){ref-type="fig"}). The consensus `(A/G)GCATTNANNCA` was found in about 40% of A1 and 45% of CRF02_AG LTRs, while `NGCAC(A/G)CAGACA` predominant in sequences from clade C (88%) was also found in LTRs from CRF22_01A1 specimens (40%). In our study, the sequence `CGCAGACA` included in this latter US2 variant was no longer strictly associated to clade C isolates as previously reported \[[@pone.0195661.ref039], [@pone.0195661.ref081]\], as it was also found in the emerging CRF22_01A1 recombinant. On the other hand, we observed that the US2 consensus `AGCA(C/A)GAAAACA` was only displayed by CRF01_AE specimens. In all the clade D and in some CRF02_AG LTRs, the US2 variant `(A/G)GCATTTGA(A/G)CA` includes the E-box motif `CATTTG` similar to what we reported earlier in clade A1 viruses (nt- 330 to -325); whereas the `AGC(C/A)(C/A)TGAGACA` consensus in CRF12_BF (80%) and F2 (60%) LTRs, contains a `TGAGACA` motif closely related to an AP-1/CREB/ATF target.

Overlapping with the US2 target, the nucleotide sequence `CACATGGC` in HXB~2~ (nt -166 to -159) contains the well described E-box consensus motif `CAC(G/A)TG` recognized by bHLHzip proteins such as USF-1 or TF3 \[[@pone.0195661.ref075], [@pone.0195661.ref082], [@pone.0195661.ref083]\]. This USF-1 consensus was mainly found in clade B LTRs (70%), in some CRF22_01A1 (20%), and in few clade C isolates (13%). At this position, additional E-boxes with non-USF-1 consensus motifs were found in clade C (50%), while none of the variants found in the other studied strains match the `CANNTG` consensus ([Fig 1D](#pone.0195661.g001){ref-type="fig"}). According to a previous study, these non-`CANNTG` variant do not interact with a recombinant USF-1 factor in vitro \[[@pone.0195661.ref084]\]. We noticed that the A5T mutation of the USF-1 variant `CACAAGGC` displayed by the clade D and few clade B LTRs, generates an Ets-like core motif (`AAGGC`). The sequence downstream of the USF-1 motif (nt -153 to -146), includes a potential GATA motif with a high variability across our dataset ([Fig 1D](#pone.0195661.g001){ref-type="fig"}). In this sequence, we also observed that the consensus `AGAAA(C/T)AT` predominant in F2 and CRF12_BF LTRs ([Fig 1D](#pone.0195661.g001){ref-type="fig"}), contains a potential recognition site for TCF/LEF family of proteins \[[@pone.0195661.ref064]\].

Contiguously, the consensus motif `(C/T)ATCCGGA` (nt -148 to -141) binding site for RBF-1/Ets-1 was found to be very well conserved across all our studied HIV-1 strains except for CRF01_AE isolates mainly in which it was changed to a `C(G/A)TCC(T/A)GA` variant as previously described \[[@pone.0195661.ref014], [@pone.0195661.ref040], [@pone.0195661.ref041]\]. Here, the RBF-1/Ets-1 target overlaps two major consensus motifs `CCG(G/C)AGT` and `CC(T/A)GAGT` (mainly CRF01_AE) in 79% and 14% of the analyzed LTRs respectively ([Fig 1D](#pone.0195661.g001){ref-type="fig"}). These two consensuses contain a motif homologous to the recognition site the ATF/CREB/AP-1 family of transcription factors. The canonical consensus for LEF-1/TCF factors commonly reported in proximity of the Ets-1 target \[[@pone.0195661.ref082]\], was found in about 60% of the non-B, non-G and non-CRF01_AE specimens in our study. For this TFBS, a `TATAA(A/G)(A/G)` variant which includes a `TATAA` motif was predominant in G (67%) and CRF01_AE (60%) isolates. Nonetheless, this `TATAA` motif has been shown to be non-functional in CRF01_AE isolates \[[@pone.0195661.ref041]\]. The highest variability was observed in clade B LTRs where only 25% of the TCF/LEF variants matched the canonical motif. Adjacent to the binding site for TCF/LEF, an insert of 7 nucleotides with the consensus motif `ACTGAGA` was specifically found in F2 and CRF 12_BF sequence. In this study, we noticed that this insert reported as a partial RBE site motif \[[@pone.0195661.ref041]\], was closely related to the AP-1- like element involved in the expression of the tumor suppressor protein p53 \[[@pone.0195661.ref085]\].

Further downstream, the `ACTGCTGA` motif of the RBEIII site (nt -129 to -122) targeted by the RBF-2 complex \[[@pone.0195661.ref022], [@pone.0195661.ref077]\], was particularly well conserved (93%) across HIV-1 clades and CRFs in our study. This RBE III intersects an AP1-like element (nt -124 to -118) that was conserved in only 25% of the clade B LTRs. Besides the most frequent variant `TGACA`[CA]{.ul} predominant in sequences from non-B, D, G and non-CRF01_AE isolates, the AP-1-like sequence displayed some strains distinctive motifs ([Fig 1D](#pone.0195661.g001){ref-type="fig"}). It was followed by the MFNLP which in accordance with previous reports \[[@pone.0195661.ref021], [@pone.0195661.ref022]\], was displayed by about 33% of the LTRs in our study. Commonly observed in LTRs from CRF22_01A1 specimens as well as in LTRs subtyped as F2, CRF12_BF (80%) and CRF02_AG (67%), this insert was less frequent (≤ 40%) in clades A1, G, C and D. It was scarcely found in LTRs subtyped as B, and was totally absent in the LTRs from CRF01_AE isolates. The MFNLP includes a duplicate of the RBEIII and/or the AP-1-like motif along with a GATA-like motif in the LTRs subtyped as CRF02_AG, CRF12_BF and F2 or a C/EBP-like motif in LTRs from clade D isolates. At the end of the modulatory segment, the US1 consensus `A(A/G)(C/A/T)TTTCTACA` found in clades B (70%) and D (80%) LTRs, was the only in our dataset to be conformed to a reported binding site for C/EBP proteins. In all the other analyzed 5'LTR sequences, the following variants were found: `(A/G)AGTT(G/A)CTGAC` in A1, G, and CRF02_AG, `AAGATTCTAA(G/A)` in F2 and CRF12_BF, while `AAGTTTCTAAC` which overlaps a TCF/LEF-like motif (`CTAACTA`) was found in CRF01_AE specimens ([Fig 1D](#pone.0195661.g001){ref-type="fig"}). In our study, there was no US1 variant in sequences from clade C isolates as previously reported \[[@pone.0195661.ref076]\], neither in LTRs from CRF22_01A1 specimens.

### U3 enhancer spanning nucleotides -104 to --80 {#sec014}

The two canonical sequences `GGGACTTTCC` for the binding of NF-κB factor in the enhancer segment of the U3 region were very well conserved. Nevertheless, with an overall percentage of similarity of 85%, NF-κB2 (nt -104 to -95) was slightly less conserved than NF-κB1 (nt -90 to -81) which showed a nucleotide similarity of about 91% with HXB2. Besides the consensus `A(G/A)GACTTCC` specifically found in CRF01_AE specimens, we observed within the NF-κB2 site some point mutations such as C9A in 20% of CRF02_AG, T6C in 40% of CRF12_BF LTRs and C10T in 40% of the LTRs from CRF22_01A1 isolates ([Fig 2](#pone.0195661.g002){ref-type="fig"}). The C10T mutation was also the most frequent NF-κB1variant and was observed only in CRF12_BF (80%) and F2 (40%) LTRs. This C10T variant found was shown to have no impact on the affinity and the functionality of the NF-κB factors \[[@pone.0195661.ref086]\]. In our study, an additional binding site for NF-kB with the consensus motif `GGGGCGTTCC` was found in majority of clade C specimens as previously reported \[[@pone.0195661.ref015], [@pone.0195661.ref041]\] and with the canonical NF-kB motif in one-third of CRF02_AG LTRs.

![Variability in the U3 enhancer and promoter region of diverse HIV-1 subtypes and CRFs.\
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The NF-κB2/ NF-κB1 interspace motif `GCTG` (nt -94 to -91) was overall well conserved. This spacer is embedded within the AP-2 recognition sequence `CCGCTGGGGA` \[[@pone.0195661.ref087], [@pone.0195661.ref088]\], and overlaps motif targeted by GABP factors. Indeed, it has been shown that GABP binds with high affinity to the variant `CTTCCG` of overlapping the NF-κB2 site of CRF01_AE viruses only; and with the low affinity to the variant `CTTTCCG` present in most of the other studied strains \[[@pone.0195661.ref015]\]. In our dataset, we observed three major variants of the interspace motif ([Fig 2](#pone.0195661.g002){ref-type="fig"}): 1) `ACTG` scattered among several specimens and predominant in CRF22_01A1, 2) `(G/A)CCT` found in clade G, and 3) `AAAG` found in CRF12_BF and F2 LTRs only. This latter variant, by overlapping NF-κB2, led to a `CTTTCCAAA` motif conformed to the canonical consensus for the binding of C/EBP proteins `((C/A)TTNCNN(C/A)A)`. Furthermore, we noticed that the mutation of the AP-2 target in CRF02_AG appeared only in LTRs containing an extra NF-κB site.

### U3 promoter spanning nucleotides -78 to --1 {#sec015}

Three sites named Sp III, Sp II and Sp I for the binding of Sp1 and related factors have been described along with the TATA box in this segment of the U3 region. In our study, the Sp binding sites displayed a high degree of intra-clade conservation and some inter-clade variability. Of the three, the sequence of the Sp III proximal to NF-κB1 displayed the highest variability ([Fig 2](#pone.0195661.g002){ref-type="fig"}). Thus, the HXB~2~ Sp III consensus motif `GAGGCGTGGC` (nt -77 to -68) was found in 20% of clade B LTR only, while specific variants, such as `GAGGCGTA(A/C)C` was found in clade D isolates, and `GAAGGCG(T/G)GCC` which include a GABP--like motif (`GAAGGC`) was found in F2 (60%) and CRF12_BF (80%) LTRs ([Fig 2](#pone.0195661.g002){ref-type="fig"}). For this TFBS, the variant `GAGGTGTGGT` (5T10T) predominant in LTRs from clades A1 and CRF02_AG viruses (≥ 80%) was also found in sequences from CRF22_01A1 (50%) and clade C (22%), and `GAGGTGTGGC` (5T) seen in all the LTRs from CRF01_AE was shared with clade B LTRs as previously observed \[[@pone.0195661.ref089], [@pone.0195661.ref090]\]. Overall, variability of the Sp III in our study was concordant with previous studies reporting a high conservation of the central Gs (`GGCG`) and the frequent C5T/A mutation \[[@pone.0195661.ref090], [@pone.0195661.ref091]\]. The HXB~2~ Sp II motif `TGGGCGGGAC` (nt -66 to -57), mainly conserved in clades B and C sequences was mutated to `TGGGCGGAGT` in LTRs from clade A1 (90%) and CRF22_01A1 (100%) viruses. In our study, Sp II strain specific variants such as `TGGGAGGG(G/A)C, TGGGAGGAGT`, and `(G/A)GGG(A/C)GGAGT` were respectively observed in LTRs from clade G, CRF02_AG and CRF01[\_]{.ul}AE specimens ([Fig 2](#pone.0195661.g002){ref-type="fig"}). These three consensus were not conformed to the GC box consensus (GGGCGGPuPuPy) reported as recognition site for Sp1 family of proteins \[[@pone.0195661.ref092]\]. Sp I proximal to the TATA box (nt -55 to -46), was the most conserved of the three targets for Sp proteins, with the consensus motif `(G/T)GGGAGTGG(C/T)` found in more than 90% of the sequences analyzed.

Overlapping with the Sp I site, the subsequent nucleotide sequence `GCGAGCCCT` in HXB~2~ (nt -47 to -39) was conserved in clade B LTRs only ([Fig 2](#pone.0195661.g002){ref-type="fig"}). In our study, this sequence displayed several variations such as `GTCAACCCT` predominant in clade C, `GTTAACCC` seen only in F2 (40%) and CRF12_BF (80%) sequences, and the consensus `GCTAACCCT` observed in most of the other studied LTRs. We noted that these variants contained a potential E-box/c-Myb element. Further downstream, the TATA box motif (`TATAA`) flanked at its 3' and 5' end by an E-box motif, was extremely well conserved in all our strains studied except for CRF01_AE and CRF22_01A1 where it was changed to `TAAAA` in 60% and 80% LTR sequence respectively ([Fig 2A](#pone.0195661.g002){ref-type="fig"}). The `CAGATG` motif of the 5'E-box predominant in almost all the LTRs analyzed, was mutated to `CAGAAG` in clade G (100%) and in CRF02_AG (33%) viruses. However, we noted that in these two HIV-1 strains, a motif similar to the 5'E-box was observed in the sequence adjacent to the US3 target located in the modulatory segment (nt -242 to -237). The 3'E-box consensus sequence `CAGCTG` reported as a binding site for bHLH factors such as AP-4 \[[@pone.0195661.ref071]\], was mainly conserved in non-G and non-CRFs specimens where the `CAGCCG` variant was predominant ([Fig 2](#pone.0195661.g002){ref-type="fig"}). Thus, unlike what was previously reported \[[@pone.0195661.ref041], [@pone.0195661.ref074]\], our study suggests that the variability of the 3'E-box motif might not be restricted to clade G and CRF01_AE isolates. The sequence between the 3'E-box and the transcriptional start site was reported to contain a target for Oct-1/Oct-2 factor \[[@pone.0195661.ref093]\]. In this sequence, the `CTTTT(T/C)GCCT` consensus (nt -15 to -6) was the major variant in non-G, non-A1 and non CRFs isolates ([Fig 2](#pone.0195661.g002){ref-type="fig"}), whereas `CTTCTCGC(C/T)T` consensus was shared by clade A1 (30%), clade G (100%) and CRF02_AG (78%) LTRs, and `CTTT(G/T)CGCTT` was predominant in CRF01_AE and CRF22_01A1 specimens.

Variability of the repeat (R) region {#sec016}
------------------------------------

The TAR element (nt 1 to 59) fold into a hairpin structure composed of a bulge, a loop and a stem. In our study, we found that all the constitutive elements of the TAR structure were affected by singles and clustered sets of mutations across different HIV-1 strains. In general, the stem displayed the highest variability followed by the bulge (nt 23 to 25, with the `TCT` motif in HXB~2~) and the loop (nt 30 to 35, with a `CTGGGA` motif in HXB~2~).

In accordance with previous reports, we found a C24T change in most of the CRF02_AG and majority of clades D, F2, and G isolates \[[@pone.0195661.ref039], [@pone.0195661.ref040]\], but also in CRF12_BF LTRs. Also, we found a deletion of T25 leading to a two nucleotides bulge in clade A1 and -CRF01_AE specimens as previously observed \[[@pone.0195661.ref005], [@pone.0195661.ref089]\], and in CRF22_01A1 as well ([Fig 3](#pone.0195661.g003){ref-type="fig"}). Furthermore, we noted that mutations of the bulge in clade A1 (60%) and CRF01_AE (80%) isolates mainly also affect the overlapping consensus `TGAGCC(T/C)` reported as a AP-1 recognition site \[[@pone.0195661.ref029]\]. The consensus motif of the loop was changed to a `CCGGGA` variant in most of the CR01_AE viruses as previously reported \[[@pone.0195661.ref089]\], and also in isolates CRF22_01A1 (60%), clades C (50%), and Al (20%). Additionally, a `CTGAGAG` variant of the loop was observed in clade D LTRs (40%) and in few sequences subtyped as A1 (10%) and B (5%). This latter variant of the loop converted the well conserved `GGGAGCTCTC` sequence reported as a NF-κB binding site \[[@pone.0195661.ref027]\], into a `GAGAGCTCTC` motif.
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Mutations in the stem principally affect the A10:51T, G11:T50, T13:A48 and A22:T40 base pairing. We observed that most of the non-B strains displayed a cluster of point mutations rather than a single point mutation ([Fig 3](#pone.0195661.g003){ref-type="fig"}). Thus, while the single mutation A48[G]{.ul} (affecting the T13:A48 pairing) was found in most of clade B LTRs, this change was associated with G11[T]{.ul} clade D or with 11[T]{.ul}22[G]{.ul} in CRF22_01A1 specimens ([Fig 3](#pone.0195661.g003){ref-type="fig"}). In clade G and CRF02_AG specimens, we observed that the pairing T11:A50 and C13:G48 were associated with various other mutations especially in CRF02_AG viruses which displayed the highest variability for this feature of the TAR element. The T:A pairing at position 11 and 50 also found in CRF01_AE and clade C isolates, was associated with 13G and 13G48T co-variation respectively. The stem overlaps the footprint of a sequence reported to contain binding sites for cellular factors such as LBP-1 (nt -4 to +21) and CTF/NF-I \[[@pone.0195661.ref094], [@pone.0195661.ref095]\].

In the Poly-A hairpin (nt 61 to 105), the polyadenylation signal motif `AATAAA` (nt 74 to 79) as well as the AP-1 target (nt 88 to 95) \[[@pone.0195661.ref096], [@pone.0195661.ref097]\], were extremely well conserved in our study ([Fig 3](#pone.0195661.g003){ref-type="fig"}). We observed that mutation affecting the stem of the poly A hairpin lead to some strains specific patterns. Thus, the `ACTGCTTAAG` sequence (nt 60 to 69) which includes a CREB-like recognition site \[[@pone.0195661.ref098]\], was changed to A`CTGCTTAAAG` in CRF01_AE and to `ACTGCTTGAAG` in CRF22_01A1 specimens. In CRF12_BF (80%) and F2 (40%) LTRs, a C61T mutation transformed the CREB-like target `ACTGCTTAA` into an `ATTGGCTTAA` motif conformed to the canonical sequence for the binding of C/EBP proteins ([Fig 3](#pone.0195661.g003){ref-type="fig"}). The highest inter-clade variability of the poly A hairpin was observed within the HXB2 sequence `TCAAGTAGT` (nt 96 to 104) ending the R region. Indeed, this motif conserved in less than one-third of our analyzed sequences, was changed in a strains specific consensus such as `CT(A/G)AG(C/T)AGT` in clade C LTRs and `TAA(A)iGTGGT` is LTRs subtyped as CRF01_AE ([Fig 3](#pone.0195661.g003){ref-type="fig"}). The variant `TTAAAGCAGT` found in CRF12_BF and F2 LTRs includes a perfect match to the consensus binding site for CREB factors \[[@pone.0195661.ref098]\]. This potential TFBS may compensate the conversion of the reported CREB-like site (nt 60 to 69) into a potential C/EBP-like observed earlier in these LTR sequences.

Discussion {#sec017}
==========

To the best of our knowledge, this study is the first to describe the diversity of the 5'LTR U3R region from diverse HIV-1 strains including the newly emerging CRF22_01A1 HIV-1 strain. The CRF01_AE subtype assigned to sequences from CRF22_01A1 may be explained by the close relation of the two strains. Indeed, it has been reported that the gag, nef and segments of the env genes of a typical CRF22_01A1 strain, can be subtyped as CRF01_AE \[[@pone.0195661.ref047], [@pone.0195661.ref052]\]. The finding of additional contigs with different subtypes that are different from the primary genotype in some of our specimens can be explained as artefacts and/or contamination during our experiment. Alternatively, they can also result from the intra-host diversity of HIV-1 population. This highlights the fact that Next-generation sequencing, by detecting low-frequency mutation \[[@pone.0195661.ref042]\], might be a more reliable tool to analyze the genetic diversity of HIV-1. The intra-host heterogeneity of HIV-1 population reflects its high mutation rate and rapid turnover, but also the co-circulation of various HIV-1 strains within the same patient. Thus, the F2 contig found in a CRF02_AG specimen from Cameroon might corroborates the recent report of dual-infection with CRF02_AG and F2 in this country \[[@pone.0195661.ref099], [@pone.0195661.ref100]\]. Three out of five contigs assigned to be CRF12_BF were from clade B specimens collected in Bolivia, Spain and Japan. In these countries, a high prevalence or emerging BF recombinant circulating along with pure B have been reported \[[@pone.0195661.ref101]--[@pone.0195661.ref105]\].

The U3R region of the HIV-1 5'LTR is involved in the control of both basal and trans-activated transcription of the HIV-1 genome though its interaction with several cellular transcription factors. Therefore, mutations affecting its nucleotide sequence might drive potentials differences in the biological property of diverse HIV-1 strains. Here, we found that the degree of genetic variability of the U3R can vary from very low to fairly high, depending on the segment analyzed. Nevertheless, it has been demonstrated that even minor changes in this region could influence the replication rate and the disease severity of HIV-1 infection \[[@pone.0195661.ref015], [@pone.0195661.ref055]\].

In the U3 modulatory segment, besides binding sites for the RBE III and Ets-1 sites that were conserved in almost all the LTRs, majority of the TFBS were distinctive of one or few HIV-1 strains. Several motifs aligned with the TFBS reported in HXB2 displayed a sequence that varied from the reported consensus. As most of the regulatory elements that were studied belonged to clade B LTRs, functions of these TFBS described in non-B strains remains to be determined. Although the affinity for C/EBP proteins of the motifs found in non-B, C and D is yet to be investigated, it has been suggested that the binding ability and functions of C/EBP proteins can be modulated by interaction with other factors such as ATF/CREB/ AP-1 \[[@pone.0195661.ref106]\], E-boxes targeted proteins \[[@pone.0195661.ref107]\], and `TATAA`-binding proteins \[[@pone.0195661.ref108]\]. This might explain the finding of potential E-box (in CRF02_AG, clades B, C, D and G), AP-1 like (clade F2, CRF12_BF and CRF22_01A1) and Ets (CRF22_01A1 and CRF01_AE) binding sites in close proximity or embedded into the reported C/EBP binding site in our sequences analyzed. Thus, the differential repartition of these TFBS according to the HIV-1 strain might probably direct a distinctive mechanism of regulation of HIV-1 transcription. As previously reported, we also observed a high variability of the GATA binding motif. This variability has addressed the affinity, specificity and function of GATA factors \[[@pone.0195661.ref109]\]. Indeed, it has been reported that the specificity of GATA binding sites along with the spanning TFBS influence the fate of GATA-3 mediated T-cell differentiation and function \[[@pone.0195661.ref110]\]. Thus, the combination of strains-specific GATA binding sites along with distinctive spanning mutations may potentially impact pathogenicity of HIV-1 according to the strain.

Several TFBS have been shown to be able to activate or repress the transcriptional activity of HIV-1 depending on their affinity with the targeted factor and the spanning nucleotides \[[@pone.0195661.ref035], [@pone.0195661.ref071], [@pone.0195661.ref083], [@pone.0195661.ref084], [@pone.0195661.ref111]--[@pone.0195661.ref113]\]. Thus, in accordance with a recent report \[[@pone.0195661.ref035]\], the presence of the AP-1 variant `TGACACA` in CRF02_AG, CRF22_01A1, CRF12_BF, as well as in clades F2, C and A1 isolates may increase their capacity to establish HIV-1 latent infection compared to other strains. This predisposition may be affected by intra-clade variability due to the duplication of this variant within the MNFLP present in some of these specimens. On the other hand, the presence of an insert motif similar to the AP-1 activator of the p53 promoter might contribute to an increase reactivation of HIV-1 in F2 and CRF12_BF, as it has been shown that p53 could reactivate HIV-1 replication from its latency in U1 cells with upregulation/activation of host transcription factors such as AP-1 (Wang; X., et al, 2017, unpublished data).

In our study, the important TATA box element as well as key TFBS such as NF-κB was fairly well conserved. In accordance with previous reports \[[@pone.0195661.ref066], [@pone.0195661.ref114]--[@pone.0195661.ref116]\], the configuration and copy number of NF-κB sites found in our study; suggest inter-strain differences of the NF-κB induced activity. Also, as suggested by our finding in CRF02_AG specimens, this activity might also vary within isolates from the same HIV-1 strain. Furthermore, the variability found in the NF-κB inter-space required for the optimal binding of factors such as NFAT, Ets and AP-2 \[[@pone.0195661.ref087], [@pone.0195661.ref088], [@pone.0195661.ref117], [@pone.0195661.ref118]\], may also favor a distinctive modulation of the NF-κB activity in CRF01_AE, CRF22_01A1, CRF12_BF and clade F2. The 5T variant of the Sp III was shown to be able to abrogate the binding of Sp1 factors \[[@pone.0195661.ref090]\], and to be associated with HIV-1 disease progression \[[@pone.0195661.ref017]\]. As the mechanism leading to faster HIV-1 disease progression observed with CRF01_AE and some clade B isolates remain to be explored \[[@pone.0195661.ref114], [@pone.0195661.ref119]--[@pone.0195661.ref121]\], the contribution of Sp III along with other TFBS specificities should be considered. Also, it was reported that Sp1 and GABP factors cooperates to activate various genes such as CD18 which overexpression during HIV-1 infection has been related to disease severity \[[@pone.0195661.ref122]\]. The potential GABP binding site included in the Sp III variant of F2 and CRF12_BF LTRs, could also differentially impact the outcome of HIV-1 infection with these isolates.

In our study, the bulge residue T23, the loop as well as paired nucleotides below (A22:T40; G21:C41) and above (G26:C39 and A27:T38) shown to be important of the TAR activity were conserved in majority of the sequence analyzed. However, strain specific mutations within and outside these the features, might explained some differences in the transcriptional activity and replication rate between subtypes and CRFs \[[@pone.0195661.ref041], [@pone.0195661.ref066]\]. Changes in the Watson-Crick complementarity observed here, might also affect the TAR structure which has been shown to be important for its function, and for the activity of the downstream 5'LTR U5 region and the Gag leader sequence \[[@pone.0195661.ref123]--[@pone.0195661.ref125]\]. Also, it has been reported that regulation of the transcriptional activity driven by TAR-tat interaction can be enhanced through synergic action with various TFBS such the AP-1 targets with a crucial role in the replication and transcription of HIV-1 \[[@pone.0195661.ref097]\]. In most of the sequence analyzed in our study, the TFBS in the R region were well conserved assuming that the biological mechanism in which these TFBS are involved might be similar for various HIV-1 strains. Nevertheless, the potential loss of one of the AP-1/ATF/CREB-like sites in CRF01_AE and CRF22_01A1 specimens, and the relocation of the CREB-like in CRF12_BF and some F2 LTRs associated with the presence of a potential C/EBP site might suggest a distinctive TAR mediated activity for these isolates.

It is known that the differential activity of the LTR due to the lack or mutation of a TFBS can be compensated by various mechanisms such as the gain of additional factors, the interplay between TFBS in close proximity or the delocalization of the TFBS. On the other hand, association of potential strains distinctive mutations in the U3R may contribute to strain-specific function of the 5'LTRs \[[@pone.0195661.ref066], [@pone.0195661.ref116]\]. For CRF01_AE isolates for example, it was suggested that its 2nt bulge (TC), 22G31C and TAAAA co-mutations promote its higher transcriptional activity and replication rate compared with clade B \[[@pone.0195661.ref041], [@pone.0195661.ref066], [@pone.0195661.ref126]\].

In this study, we have reported distinguishing patterns within and outside the reported regulatory element in the U3R region from diverse HIV-1 strains. Due to the important role of this region in the control of the HIV-1 transcription, it is reasonable to suggest that strain specific variability greatly contributed to the effectiveness of replication and gene expression of different HIV-1 subtypes and CRFs. Intra and inter-clade variability of the U3R region should be further explored in future studies related to the replicative capacity and pathogenicity of HIV-1, as this may lead to a better understanding of phenotypic effects of HIV-1genetic diversity.
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